Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein light chain Tctex-type 2B (DYNLT2B) is a non-catalytic accessory protein that forms part of the cytoplasmic dynein-2 complex, a multi-subunit microtubule motor responsible for retrograde intraflagellar transport (IFT) in cilia and flagella[4][5]. In the dynein-2 complex, DYNLT2B serves as a unique Tctex-type light chain, interacting with specific intermediate chains such as WDR34 and WDR60 to ensure proper complex assembly and function[1][3]. DYNLT2B is essential for the movement of cargos from the ciliary tip toward the base and thus plays a vital role in ciliary and flagellar function. Mutations in DYNLT2B are associated with ciliopathies, most notably short-rib thoracic dysplasia 17 with or without polydactyly, a severe congenital disorder affecting skeletal and lung development[5]. There is currently no established therapeutic targeting or drug interaction for this protein, and its primary significance lies in its structural and transport functions within the dynein-2 motor complex[2][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein light chain Tctex-type 2B (DYNLT2B).